Wolfe Peter

ZyVersa Therapeutics, Inc. · Chief Financial Officer

Wolfe Peter is listed in filings as Chief Financial Officer at ZyVersa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 15, 2025, including 1 public disclosure. Recent filings connect the profile to ZyVersa Therapeutics, Inc. (ZVSA). The current snapshot covers public activity from Jul 15, 2025. Reported amounts are shown as $35.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.